Scientists say HHS’ decision to defund mRNA vaccine research will leave the country less prepared for pandemics, and make it ...

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

Covid-era coercion and misinformation bred public distrust, but the vaccines did save countless lives.

Illinois researchers, including some working on vaccines for cancer and rare diseases, worry the federal government turning ...

Over the past six months, Moderna’s shares (currently trading at $25.79) have posted a disappointing 19.2% loss, well below ...

The U.S. government announced funding cuts to mRNA vaccine research. What is the impact on American healthcare and biotech?

Biotechnology company Moderna (NASDAQ:MRNA) announced better-than-expected revenue in Q2 CY2025, but sales fell by 41.1% year ...

The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be ...

The average short interest in the S&P 500 Health Care Index Sector (XLV) dipped slightly in July to 1.95% from 1.96% in June.

With that in mind, let's consider two stocks that people in their 30s -- who are still a good distance away from retirement - ...

Enphase Energy (ENPH) retained its spot as the most shorted S&P 500 (SP500) stock as a percentage of float in July, followed ...

Antipathy from figures close to Trump toward mRNA technology, which underlies Moderna’s products and pipeline, has weighed on ...